Prof. Amy Finkelstein speaks with Marketplace’s David Brancaccio about her new book “We’ve Got You Covered: Rebooting American Health Care,” which outlines a way to rethink health care in the U.S. “What every other high-income country does is have universal basic coverage with the ability to buy additional supplemental coverage for people who can afford and want more than that basic coverage,” explains Finkelstein. “And that’s what we need to do.”
Writing for The Washington Post, research affiliate Bina Venkataraman emphasizes that “if biomedical breakthroughs are to benefit the millions of children afflicted with rare diseases, genetic testing of babies needs to expand.” Venkataraman adds: “By screening newborn genomes for currently known genetic diseases, patients and scientists could gain insights that lead to the treatment and prevention of thousands of illnesses that currently lack cures.”
Forbes reporter Marco Annunziata spotlights Prof. Amy Finkelstein’s new book, “We’ve Got You Covered.” Annunziata writes that “the book underscores the stunning absence of a health care budget," adding that the authors "do a great job at highlighting how the current setup poses no limit to expenditures and encourages doctors and providers to run up larger bills.”
Prof. Daniela Rus, director of CSAIL, writes for Forbes about Prof. Dina Katabi’s work using insights from wireless systems to help glean information about patient health. “Incorporating continuous time data collection in healthcare using ambient WiFi detectable by machine learning promises an era where early and accurate diagnosis becomes the norm rather than the exception,” writes Rus.
Researchers from MIT and Massachusetts General Hospital have developed “Sybil,” an AI tool that can detect the risk of a patient developing lung cancer within six years, reports Mary Kekatos for ABC News. “Sybil was trained on low-dose chest computer tomography scans, which is recommended for those between ages 50 and 80 who either have a significant history of smoking or currently smoke,” explains Kekatos.
In an article for The Boston Globe, Prof. Emeritus Ernest Moniz explores the risks associated with the cesium-137 devices used in hospitals. “Boston hospitals have an opportunity to receive tens of thousands of dollars of grants toward the purchase of new equipment that is just as effective for medical and research purposes as the radiological devices they have been using for decades,” writes Moniz, “while shedding the liabilities and security costs associated with cesium sources.”
In an article for Forbes, research affiliate John Werner spotlights Prof. Dina Katabi and her work showcasing how AI can boost the capabilities of clinical data. “We are going to collect data, clinical data from patients continuously in their homes, track the symptoms, the evolution of those symptoms, and process this data with machine learning so that we can get insights before problems occur,” says Katabi.
Michael Goldberg PhD '08 founded Surge Therapeutics, a company developing a hydrogel immunotherapy treatment aimed at reducing the risk of surgically-removed cancers returning, reports India Rice for Forbes. “Broadly speaking, immunotherapy is a range of cancer treatments that aim to strengthen the immune system’s ability to fight cancer,” explains Rice. “But what makes Surge’s solution different is that it’s applied during surgery as opposed to other immunotherapies that are delivered weeks before or weeks after surgery.”
Writing for The New York Times, MIT Prof. Amy Finkelstein and Stanford Prof. Liran Einav note that health insurance coverage for the Americans "who are fortunate enough to have insurance is deeply flawed.” Finkelstein and Einav make the case that the solution to health insurance reform is “universal coverage that is automatic, free and basic.”
Prof. Regina Barzilay speaks with Nicole Estephan of WCVB-TV’s Chronicle about her work developing new AI systems that could be used to help diagnose breast and lung cancer before the cancers are detectable to the human eye.
Wall Street Journal reporter Emily Bobrow spotlights Laurel Braitman PhD '13 for her work teaching writing and communication skills to healthcare workers. “We need people who are trained in science and medicine to be able to tell stories about what matters in public health in a way that makes people listen,” says Braitman. “But to do that, they have to be in touch with what they really feel.”
Prof. Marzyeh Ghassemi speaks with NPR host Kate Wells about a decision by the National Eating Disorders Associations to replace their helpline with a chatbot. “I think it's very alienating to have an interactive system present you with irrelevant or what can feel like tangential information,” says Ghassemi.
Prof. Bruce Walker and his team have found that CD8+ T cells can allow HIV patients to control the virus without the use of medications, reports Alan Mozes for HealthDay. “About one in 300 people are able to control HIV without the need for medications,” says Walker. “[It appears] that it is the CD8+ T cell response that achieves this control.”
Soledad O’Brien spotlights how researchers from MIT and Massachusetts General Hospital developed a new artificial intelligence tool, called Sybil, that an accurately predict a patient’s risk of developing lung cancer. “Sybil predicted with 86 to 94 percent accuracy whether a patient would develop lung cancer within a year,” says O’Brien.
Prof. Marzyeh Ghassemi speaks with NPR host Emily Kwong and correspondent Geoff Brumfiel about how artificial intelligence could impact medicine. “When you take state-of-the-art machine-learning methods and systems and then evaluate them on different patient groups, they do not perform equally,” says Ghassemi.